Closing Bell: Medicenna Therapeutics Corp down on Monday (MDNA)

Today, Medicenna Therapeutics Corp opened at $2.19 and closed at $2.06. prices ranged from a low of $2.06 to a high of $2.25.

The price shrank -7.21% from the previous day's close of $2.22.

During the day across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).

Trading volume was 37,880 on 99 total trades, while having an average volume of 82,699 over the last 5-days.

Trading across the entire TSX saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 52 weeks, Medicenna Therapeutics Corp's shares have risen 261.40 percent, while this year, they have risen 390.48%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $166.01 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp is holding an average recommendation of "Strong Buy" from 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..